The new risk score, developed by Emory researchers, could be a useful tool for determining overall and progression-free survival after immunotherapy.
Jonathan Wosen, PhD
Jonathan Wosen is a freelance science journalist who holds a PhD in immunology from Stanford University. He has written for STAT News, Stanford University School of Medicine, the Santa Cruz Sentinel, and Genetic Engineering & Biotechnology News. Jonathan is currently enrolled in the UC Santa Cruz Science Communication Program.